Biotech

All Articles

Zephyrm seeks Hong Kong IPO to fund period 3 cell therapy trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, declaring (PDF) for an ...

Frazier Life Sciences collects $630M for little, mid-cap biotechs

.Frazier Everyday life Sciences has sourced an even further $630 million for its own fund concentrat...

GigaGen achieves up to $135M BARDA dollars to beat botulism

.Antitoxin connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own tech ...

GPCR firm Septerna declare IPO on durability of preclinical records

.Septerna will figure out just how a biotech without "any kind of purposeful medical information" me...

Kurma shuts initially $154M haul for most significant biotech fund yet

.European VC company Kurma Allies has introduced its newest biotech fund, along with 140 thousand eu...

Prothena advertises one director while another places-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootings an...

Editas capitalize Tip Cas9 licensing civil rights for $57M

.Versus the background of a Cas9 patent struggle that rejects to perish, Editas Medicine is moneying...

Ultragenyx modifies gene therapy application to call up effectiveness

.A minority of people taking Ultragenyx Drug's Wilson disease genetics therapy UX701 have come off s...

Biopharma layoff rate stabilizes in Q3: Brutal Biotech review

.As summer months heat energy relies on cool down winds, wishes that this year would certainly carry...

J &amp J falls phase 2 dengue prospect in most current switch from vaccines

.Johnson &amp Johnson's deprioritization of its own contagious health condition pipeline has profess...